Biolife Funding: How Much Did They Raise & Key Investors

How Much Did Biolife Raise?
Funding & Key Investors

Biolife, a developer of innovative medical device products, has seen significant financial activity, with a total funding amount of $350K and a recent funding amount of $350K. The company's recent strategic investment underscores its potential in critical patient care solutions, particularly in wound management and hemostasis. This financial backing positions Biolife for continued development and market penetration.

What is Biolife?

Biolife

Manufacturing

Medical Devices & Equipment

Biolife is recognized for its development of advanced medical device products, including the StatSeal® and WoundSeal® technologies. These innovations are designed to address critical needs in patient care, specifically in areas of wound management and hemostasis. The company's focus on creating effective and reliable tools aims to improve clinical outcomes for healthcare providers.

How much funding has Biolife raised?

Biolife has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in Biolife

PPP

Public-Private Partnership

What's next for Biolife?

Following its acquisition by Merit Medical Systems, Biolife's trajectory is now integrated into a larger healthcare solutions provider. This strategic move by Merit Medical Systems aims to enhance its portfolio by incorporating Biolife's specialized products. The integration is expected to strengthen Merit's ability to offer comprehensive solutions, particularly in wound care, and leverage Biolife's technological advancements for broader market impact and continued innovation in patient treatment.

See full Biolife company page

See More Financial Insights